Askel Healthcare to Present First Clinical Trial Results of Its COPLA® Knee Cartilage Implant at the 9th Joint Preservation Congress in Warsaw, Poland on June 14-15, 2024

Posted on by

HELSINKI, June 14, 2024 /PRNewswire/ — Askel Healthcare, a Finnish medical technology company pioneering the treatment and repair of focal knee cartilage defects, will present results from its first-in-human Pilot Clinical Trial at the 9th Joint Preservation Congress in Warsaw on June…

Posted in UncategorizedTagged
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.